Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

RPID stock hub

Rapid Micro Biosystems, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

RPIDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

120.4M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

RPID

In the news

Latest news · RPID

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-86.8

P25 -106.6P50 -46.9P75 -3.1

ROIC-42.7

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All RPID market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

205

Groups with data

Currency

USD

Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001380106
Company name	Rapid Micro Biosystems, Inc.
Country	United States
Country code	US
Cusip	75340L104
Employees	171
Employees Change	8%
Employees Change Percent	4.91
Enterprise value	$105.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
IPO Date	2021-07-15
Isin	US75340L1044
Last refreshed	2026-05-10
Market cap	$120.4M
Market cap category	Micro-Cap
Price	$2.63
Price currency	USD
Rev Per Employee	196,415.2x
Sector	Healthcare
Sic	3826
Symbol	RPID
Website	https://www.rapidmicrobio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-39.15%
EV Sales Forward	2.64x
EV/Sales	3.14x
FCF yield	-26.51%
P/B ratio	3.52x
P/S ratio	3.58x
PS Forward	3.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-141.1%
EBITDA Margin	-132.91%
Gross margin	3.12%
Gross Profit	$1M
Net Income	$-47.1M
Net Income Growth Years	0%
Pretax Margin	-140.18%
Profit Margin	-140.3%
Profit Per Employee	$-275,573
ROA	-34.24
Roa5y	-23.7
ROCE	-84.08
ROE	-86.82
Roe5y	-52.58
ROIC	-42.74

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	13.37%
Cagr3y	43.49%
EPS Growth Years	5
Revenue Growth	19.74x
Revenue Growth Q	37.28x
Revenue Growth Quarters	12x
Revenue Growth Years	3x
Revenue Growth3 Y	25.15x
Revenue Growth5 Y	15.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.39
Assets	$74.9M
Cash	$38.7M
Current Assets	$61.2M
Current Liabilities	$18.5M
Debt	$23.9M
Debt Equity	$0.72
Equity	$33.2M
Interest Coverage	-43.48
Liabilities	$41.6M
Long Term Assets	$13.7M
Long Term Liabilities	$23.2M
Net Cash	$14.9M
Net Cash By Market Cap	$12.34
Net Cash Growth	-67.03%
Net Debt Equity	$-0.45
Tangible Book Value	$33.2M
Tangible Book Value Per Share	$0.75
WACC	11.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.31
Inventory Turnover	1.72
Net Working Capital	$5.3M
Quick ratio	2.27
Working Capital	$42.7M
Working Capital Turnover	$0.63

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.53%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	13.36%
200-day SMA	3.28
3Y total return	195.51%
50-day SMA	2.74
50-day SMA vs 200-day SMA	50under200
All Time High	27.04
All Time High Change	-90.27%
All Time High Date	2021-08-03
All Time Low	0.58
All Time Low Change	353.45%
All Time Low Date	2024-07-03
ATR	0.17
Beta	1.53
Beta1y	1.69
Beta2y	1.09
Ch YTD	-9.31
High	2.7
High52	4.94
High52 Date	2026-01-29
High52ch	-46.76%
Low	2.53
Low52	2.01
Low52 Date	2026-03-30
Low52ch	30.85%
Ma50ch	-3.84%
Premarket Change Percent	-2.34
Premarket Price	$2.5
Premarket Volume	100
Price vs 200-day SMA	-19.72%
RSI	56.57
RSI Monthly	46.55
RSI Weekly	43.75
Sharpe ratio	0.55x
Sortino ratio	0.9
Total Return	-2.53%
Tr YTD	-9.31
Tr1m	21.2%
Tr1w	3.95%
Tr3m	-32.04%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.25
Earnings Revenue Estimate	7,580,000x
Earnings Revenue Estimate Growth	5.2x
Operating Income	$-47.4M
Operating margin	-141.1
Price target	$8
Price Target Change	$204

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	27,412,273%
Float Percent	59.9%
Net Borrowing	19,970,000
Shares Insiders	3.04%
Shares Institutions	19.14%
Shares Out	45,767,040
Shares Qo Q	-0.75%
Shares Yo Y	2.53%
Short Float	1.98%
Short Ratio	2.29
Short Shares	1.19

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-35.9M
Average Volume	161,236.1x
Bv Per Share	0.75
CAPEX	$-850,000
Ch1m	21.2
Ch1w	3.95
Ch1y	13.36
Ch3m	-32.04
Ch3y	195.5
Ch6m	-15.16
Change	2.73%
Change From Open	2.33
Close	2.56
Days Gap	0.39
Depreciation Amortization	2,752,000
Dollar Volume	195,877.1
Earnings Date	2026-05-13
Earnings Time	amc
EBIT	$-47.4M
EBITDA	$-44.6M
EPS	$-1.05
F Score	3
FCF	$-31.9M
FCF EV Yield	-30.24x
FCF Per Share	$-0.7
Financing CF	19,771,000
Fiscal Year End	December
Founded	2,006
Income Tax	$40,000
Investing CF	14,329,000
Ipr	-86.85
Iprfo	-88.31
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-12
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-12
Ma150	3.34
Ma150ch	-21.28%
Ma20	2.37
Ma20ch	11.21%
Net CF	3,038,000
Next Earnings Date	2026-05-13
Open	2.57
Optionable	No
Position In Range	58.82
Post Close	2.63
Postmarket Change Percent	2.66
Postmarket Price	$2.7
Ppne	13,081,000
Pre Close	2.56
Price Date	2026-05-08
Ptbv Ratio	3.62
Relative Volume	0.46x
Revenue	33,587,000x
SBC By Revenue	12.01x
Share Based Comp	4,033,000
Tax By Revenue	0.12x
Tr6m	-15.16%
Us State	Massachusetts
Volume	74,478
Z Score	-8.85

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does RPID pay a dividend?

Capital-return profile for this ticker.

Performance

RPID stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns RPID?

Insider, institutional, and short-interest positioning.

Institutional ownership

+19.1%

Float: +59.9% of shares outstanding

Insider ownership

+3.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

RPID momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.6

Neutral momentum band

Price vs 200-day MA

-19.7%

50/200-day relationship not available

Beta (5Y)

1.53

More volatile than the market

Sharpe ratio

0.55

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About RPID

Hub-level FAQ points readers to the deeper analysis pages.

What is the current RPID stock rating?

Rapid Micro Biosystems, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full RPID analysis?

The full report lives at /stocks/RPID/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for RPID?

The latest report frames RPID around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the RPID page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.